Education Interventions Model for Rational Drug Use
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 120
- 试验地点
- 2
- 主要终点
- Knowledge of Asthma
研究概览
简要总结
The purpose of this study is to develop, implement and evaluate an economically viable and efficient interventions education model for rational drug use, adaptable to different pathological situations and should be implemented into Brazil Heath Care System.
详细描述
Currently, the educational interventions regarding the use of medicines need to be expanded and more effective, and thus set themselves up in strategies for reorganization of dispensing drugs in health services and provide support to the population to obtain greater control over their health. The pharmacist, in turn, inserted in the multidisciplinary team has an important role in health education with the aim of improving knowledge about the disease and the various treatment options, reflecting positively on treatment adherence and clinical outcomes as a result and quality of life related to patient health. Thus, health education, to share knowledge, represents an important task and involves attentive listening to the community to identify their needs and then solve them. From this perspective, therefore, the educational means to educate health and an integral formation of individuals as social actors critics who understand and question the social relations, transforming subjects into citizens participating in the process of health education, helping to raise awareness , knowledge and understanding of living conditions and relationships with health, promoting quality of life.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Single Group
- 主要目的
- Other
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Subject with asthma diagnosed according to criteria of the Global Strategy for Asthma Management and Prevention;
- •Subject is a male or female with 18 to 73 years-old;
- •Subject who has access to medications supplied by the the Brazil Heath Care System;
- •Subject unable to perform the procedures or conditions such as pregnancy that may affect the results of the study;
- •Literate subject without Cognitive Disorders, Alzheimer's, Dementia, that can limit the ability to participate in this study;
- •Subject who have availability to attend the monthly meetings;
- •Subject provides written informed consent and attend the first evaluation.
排除标准
- •Subject who cannot be classified in the inclusion criteria.
研究组 & 干预措施
Pharmaceutical Education
The patients will receive pharmaceutical education.
干预措施: Education interventional (Behavioral)
Control
结局指标
主要结局
Knowledge of Asthma
时间窗: 6 months after the first evaluation
To compare the patient´s knowledge of asthma before and after the education interventions with asthma knowledge questionnaire.
次要结局
- Spirometry Exam(6 months after the first evaluation)
- Treatment compliance evaluation(6 months after the first evaluation)
- Economic analysis(6 months after the first evaluation)
- Sociodemographic data, clinical and lifestyle evaluation(6 months after the first evaluation)
- Management of inhalers(6 months after the first evaluation)
- Quality of Life Evaluation(6 months after the first evaluation)
研究者
Carolina Maria Xaubet Olivera
Masters
University of Sao Paulo